Cardiac: Page 3
-
CMS covers cardiac ablation in ambulatory surgery centers
Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.
By Susan Kelly • Nov. 26, 2025 -
Okami raises $45M to commercialize vascular embolization devices
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
By Nick Paul Taylor • Nov. 24, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Q&A
Shockwave’s Nick West on shaking up treatment for blocked arteries
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.
By Susan Kelly • Nov. 21, 2025 -
Philips, Edwards team on AI-based guide for mitral valve repair
Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures.
By Susan Kelly • Nov. 19, 2025 -
Medtronic’s PFA business is heating up
Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s 2026 fiscal year, amid mounting competition in the space.
By Ricky Zipp • Nov. 18, 2025 -
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device.
By Susan Kelly • Nov. 17, 2025 -
Q&A
Medtronic’s Jason Fontana on ramping up renal denervation
The general manager for the business says building a market is something the medtech giant knows how to do.
By Susan Kelly • Nov. 5, 2025 -
Edwards CFO Scott Ullem to exit post
Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.
By Susan Kelly • Oct. 31, 2025 -
3 takeaways from TCT 2025
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
By Susan Kelly • Oct. 31, 2025 -
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
By Susan Kelly • Oct. 29, 2025 -
Medtronic links renal denervation to 3-year blood pressure reduction
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.
By Nick Paul Taylor • Oct. 28, 2025 -
Profile
Corcym, CardioPrecision set sights on robotic heart valve replacement
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.
By Susan Kelly • Oct. 27, 2025 -
Boston Scientific continues to win in electrophysiology
Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.
By Ricky Zipp • Oct. 22, 2025 -
Ōura to pursue FDA clearance of blood pressure feature for smart ring
The company has received approval to validate and define the feature in a study that is scheduled to start this year.
By Nick Paul Taylor • Oct. 20, 2025 -
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
By Elise Reuter • Oct. 15, 2025 -
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
By Nick Paul Taylor • Oct. 15, 2025 -
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
By Nick Paul Taylor • Oct. 14, 2025 -
Medtronic wins CE mark for Penditure LAA exclusion device
The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
By Nick Paul Taylor • Oct. 3, 2025 -
Boston Scientific aims for market leadership in electrophysiology
The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.
By Elise Reuter • Oct. 2, 2025 -
Boston Scientific unveils plans for new Watchman device
The company hopes to launch its next-generation Watchman system in the second half of 2027 or early 2028.
By Elise Reuter • Updated Oct. 14, 2025 -
Heartflow receives FDA clearance for updated plaque analysis platform
The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.
By Nick Paul Taylor • Sept. 25, 2025 -
Cardiosense names Eric Meizlish as CEO
Cardiosense’s switch to a leader with experience scaling healthtech companies comes as it works to build on the recent 510(k) clearance of CardioTag.
By Nick Paul Taylor • Updated Sept. 25, 2025 -
J&J’s Abiomed starts third heart pump controller recall since June
As of Aug. 27, the company had reported five serious injuries and no deaths associated with the issue.
By Nick Paul Taylor • Sept. 24, 2025 -
Profile
How SS Innovations is expanding robotic surgery’s reach
Heart surgeon Sudhir Srivastava saw a global need for less-invasive surgical care at an affordable price. His company, SS Innovations, built a robot that has now been used in more than 5,000 surgeries.
By Susan Kelly • Sept. 22, 2025 -
FDA posts early alert about Abbott’s Tactiflex Ablation Catheter
Catheter tips came off three damaged devices during surgery but none of the patients suffered serious injuries or died.
By Nick Paul Taylor • Updated Sept. 22, 2025